Clobetasol dipropionate 0.05% versus testosterone propionate 2% topical application for severe vulvar lichen sclerosus
- 1 January 1998
- journal article
- Published by Elsevier
- Vol. 178 (1) , 80-84
- https://doi.org/10.1016/s0002-9378(98)70631-3
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Treatment of Vulvar Lichen Sclerosus in the ElderlyObstetrical & Gynecological Survey, 1995
- Topical testosterone in the treatment of vulvar lichen sclerosusInternational Journal of Gynecology & Obstetrics, 1994
- The treatment of vulval lichen sclerosus with a very potent topical steroid (clobetasol Propionate 0.05%) creamBritish Journal of Dermatology, 1991
- Contact dermatitis from clobetasol propionateContact Dermatitis, 1987
- Vulvar DystrophyClinical Obstetrics and Gynecology, 1985
- Use of the carbon dioxide laser for relief of pruritus in vulval dystrophiesJournal of Obstetrics and Gynaecology, 1984
- Further observations on the effect of topical progesterone on vulvar diseaseAmerican Journal of Obstetrics and Gynecology, 1979
- Vulvar dystrophies: An evaluationAmerican Journal of Obstetrics and Gynecology, 1974
- Treatment of vulvar dystrophies with topical testosterone propionateAmerican Journal of Obstetrics and Gynecology, 1971
- Postmenopausal Pruritus VulvaeAmerican Journal of Obstetrics and Gynecology, 1945